𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sodium benzoate in the treatment of acute hepatic encephalopathy: A double-blind randomized trial

✍ Scribed by S. Sushma; S. Dasarathy; Dr. Rakesh K. Tandon; Satish Jain; Surya Gupta; Mahender S. Bhist

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
842 KB
Volume
16
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Lactitol vs. lactulose in the treatment
Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: A double-blind, randomized trial
✍ Marsha Y. Morgan; Katherine E. Hawley πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 725 KB

Lactitol (fl-galactosido-sorbitol) is a nonabsorbable disaccharide available as a powder which, in open comparison, is as effective as lactulose in the treatment of chronic hepatic encephalopathy, but is better tolerated. Twenty-five cirrhotic patients experiencing 28 episodes of acute hepatic encep

A double-blind randomized controlled tri
A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis
✍ Sylvie Naveau; Sylvie Chollet-Martin; SΓ©bastien Dharancy; Philippe Mathurin; Pau πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 1 views

for the Foie-Alcool group of the Association Franc ¸aise pour l'Etude du Foie (AFEF)\*\* Tumor necrosis factor-␣ (TNF-␣) may contribute to the progression of acute alcoholic hepatitis (AAH). The aim of this study was to evaluate the efficacy of an association of infliximab and prednisolone at reduci

Gabapentin in the treatment of fibromyal
Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial
✍ Lesley M. Arnold; Don L. Goldenberg; Sharon B. Stanford; Justine K. Lalonde; H. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 168 KB πŸ‘ 3 views

## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin

(+)-Cyanidanol-3 in the Treatment of Acu
(+)-Cyanidanol-3 in the Treatment of Acute Viral Hepatitis: A Randomized Controlled Trial
✍ Hans Schomerus; Karl H. Wiedmann; Wolfgang DΓΆlle; Herrmann Peerenboom; Georg Str πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 461 KB πŸ‘ 1 views

One-hundred sixty patients (81 cyanidanol, 79 placebo) were included in a double-blind placebo-controlled clinical trial to evaluate the effect of 3 gm (+)-cyanidanol-3 per day for 8 weeks on the clinical course of acute viral hepatitis and HBsAg elimination. Quantitative determination of HBsAg was